Published on Holland & Knight The FDA has released new draft guidance outlining expedited pathways for regenerative medicine therapies....

Published on Technology Networks Researchers at USC Norris and City of Hope engineered CAR T cells that deliver IL-12 fused to a PD-L1...

Published on Bloomberg A new Bloomberg feature examines how experimental low-cost cancer treatments are reshaping debates around drug...

Published on Bayer Bayer’s AskBio has randomized the first European participants in its Phase II trial of AB-1005, an investigational...

Published on BlueRock Therapeutics BlueRock Therapeutics has treated the first Parkinson’s disease patient in its pivotal Phase III trial...

Published on Phys.org Researchers are developing strategies to improve the safety of stem cell therapies, focusing on reducing potential...

Published on RAPS The US FDA has released updated guidance documents covering cell and gene therapies and regenerative medicine. These...

Published on The Scientist Researchers are advancing patient-derived dendritic cell immunotherapy as a personalized cancer treatment. By...

Published on Stem Cell Research & Therapy A recent study in Stem Cell Research & Therapy explores how bone marrow-derived stem cells...

Published on Alliance for Regenerative Medicine (LinkedIn) Two landmark therapies, Zolgensma and Yescarta, highlight how cell and gene...

Published on LinkedIn (via Spencer Knight) The FDA has approved Inliruqo™ (imlunestrant) from Eli Lilly, the first oral estrogen receptor...

Published on Cytotherapy A new perspective warns that restructuring advanced therapy oversight within the European Medicines Agency could...

Published on Mayo Clinic News Network Mayo Clinic researchers report that fat-derived mesenchymal stem cells can help prevent vein...

Published on Sky News A breakthrough gene therapy called AMT-130 has slowed progression of Huntington’s disease by as much as 75% in a...

Published on Drug Target Review USC Stem Cell scientists have created kidney assembloids that function like real organs, combining...

Published on Alliance for Regenerative Medicine The Alliance for Regenerative Medicine’s A-Gene initiative demonstrates how Quality by...

Published on Alliance for Regenerative Medicine The Alliance for Regenerative Medicine’s A-Cell initiative showcases how Quality by...

Published via FDA & EU regulatory updates The FDA has approved TREMFYA® as the first and only IL-23 inhibitor with both subcutaneous and...

Published in Frontiers in Bioengineering and Biotechnology A new review highlights mitochondria as central regulators of pluripotency,...

Published on LinkedIn (via Spencer Knight) Pfizer announced plans to acquire Metsera for up to $4.9B, adding GLP-1 and amylin-based...